Non-Invasive Quantification of Vaccine-Mediated Antigen Delivery to
疫苗介导的抗原递送的无创定量
基本信息
- 批准号:7984054
- 负责人:
- 金额:$ 21.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-25 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:APC VaccineAdjuvantAntigen-Presenting CellsAntigensB-LymphocytesCancer ModelCancer VaccinesCellsComputer softwareContrast MediaEvaluationGenerationsImmune responseImmunityIn SituLabelMagnetic Resonance ImagingMalignant neoplasm of lungMeasuresMediatingMethodsModelingMolecularMonitorMonoclonal AntibodiesMusNanotechnologyPeptidesPhenotypeProcessPropertyResolutionSignal TransductionSiteStagingSystemT-LymphocyteTechniquesTechnologyTherapeuticTumor AntigensVaccinationVaccine AdjuvantVaccine AntigenVaccinesarmbasecellular imagingclinical applicationin vivoiron oxidelymph nodesmouse modelpre-clinicaltherapeutic proteintraffickingtumorvaccine-induced immunity
项目摘要
A major parameter limiting immune responses to vaccination is the number of activated antigen presenting cells (APCs) that capture antigen from the vaccine site and migrate to draining lymph nodes (LNs), the site where T and B cell priming occurs. Currently, a quantitative non-invasive technique for monitoring in vivo antigen capture and dehvery is laclting. The use of cellular magnetic resonance imaging (MRI) is a promising approach for this purpose; however, cellular imaging currently requires ex vivo pre-labeling of cells with contrast agents followed by reintroduction of cells into the subject being monitored. Using mouse models, we have developed an in vivo labehng method which relies upon the capture of vaccine antigen-associated superparamagnetic iron oxide (SPIO) by endogenous antigen presenting cells, in situ, in order to quantify AFC delivery to LNs. In this system, MRI is capable of monitoring the trafficking of magnetically labeled APCs in vivo that are responsible for inducing tumor-specific immune responses. Analysis of lymph node MR images using dedicated software enables signal quantification through the generation of pixel intensity histograms. Excellent correlation is observed between in vivo and ex vivo quantification of vaccine antigen-loaded APCs, with resolution sufficient to detect increased APC trafficking elicited by an adjuvant. Furthermore, APCs that capture SPIO (and antigen) and traffic to LN can subsequently be magnetically recovered ex vivo, allowing for detailed cellular and molecular studies of the upstream parameters that influence the afferent arm of vaccine-induced immunity.
Using murine vaccine models targeting lung cancer, we now propose to examine the correlation between the extent of APC trafficking as measured by MRI and the quantity and quality of the downstream immune response.
This information will be used to evaluate candidate vaccine adjuvants for their ability to augment this critical step In generating systemic immunity. We will also extend this technology to additional vaccine platforms setting the stage for clinical application.
限制免疫应答的一个主要参数是活化的抗原提呈细胞(APCs)的数量,这些细胞从疫苗部位捕获抗原并迁移到引流淋巴结(LNs),即T和B细胞启动的部位。目前,一种用于监测体内抗原捕获和递送的定量非侵入性技术是哺乳。使用细胞磁共振成像(MRI)是一种很有前途的方法;然而,细胞成像目前需要用造影剂对细胞进行离体预标记,然后将细胞重新引入被监测的受试者体内。利用小鼠模型,我们开发了一种体内标记方法,该方法依赖于内源性抗原呈递细胞原位捕获疫苗抗原相关的超顺磁性氧化铁(SPIO),以量化AFC向LNs的递送。在该系统中,MRI能够监测体内磁标记apc的运输,这些apc负责诱导肿瘤特异性免疫反应。使用专用软件分析淋巴结MR图像,通过生成像素强度直方图实现信号量化。在疫苗抗原负载APC的体内和体外定量之间观察到极好的相关性,其分辨率足以检测由佐剂引起的APC贩运增加。此外,捕获SPIO(和抗原)并传输到LN的apc随后可以在体外磁回收,从而允许对影响疫苗诱导免疫传入臂的上游参数进行详细的细胞和分子研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HYAM Isaac LEVITSKY其他文献
HYAM Isaac LEVITSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HYAM Isaac LEVITSKY', 18)}}的其他基金
Non-Invasive Quantification of Vaccine-Mediated Antigen Delivery to
疫苗介导的抗原递送的无创定量
- 批准号:
8545551 - 财政年份:2010
- 资助金额:
$ 21.5万 - 项目类别:
VACCINATION IN COMBINATION WITH IMATINIB MESYLATE FOR CHRONIC MYELOID LEUKEMIA
联合甲磺酸伊马替尼治疗慢性粒细胞白血病的疫苗接种
- 批准号:
7604589 - 财政年份:2006
- 资助金额:
$ 21.5万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 21.5万 - 项目类别: